Beyond a static database, the nEMLs repository serves as a collaborative tool inviting contributions from Member States, WHO regional offices and researchers to ensure completeness and relevance. It serves as a foundation for evidence-based decision-making, medicine procurement, and health-care policy harmonization.
The launch of the National Essential Medicines Lists repository marks a significant step forward in global health-care collaboration,” said Deus Mubangizi, WHO’s Director of the Health Products Policy and Standards Department. “By providing a centralized and accessible platform, we are equipping policymakers, health-care professionals and researchers with the critical data needed to make informed decisions and foster equitable access to essential medicines worldwide.
The development of this database was supported by Dr Nav Persaud, from the Department of Family and Community Medicine at the University of Toronto and St. Michael’s Hospital in Toronto, Canada.
By the numbers: The repository includes 47 national lists from the WHO African Region, 18 from the Eastern Mediterranean, 31 from Europe, 22 from the Americas Region, 11 from Southeast Asia, and 21 from the Western Pacific Region.
Each list reflects a nation’s unique health-care needs, priorities, and challenges.
By consolidating these essential medicines lists, WHO strengthens global health systems and promotes shared knowledge for improved health-care access worldwide.
Related